Bevacizumab Versus Docetaxel/Erlotinib on Tumor Metrics in Patients With Previously Untreated Advanced Non Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer Intervention: Sponsor: Hellenic Cooperative Oncology Group Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2020 Category: Research Source Type: clinical trials
Erlotinib for Hepatocellular Carcinoma Chemoprevention
Condition: Cirrhosis, Liver Intervention: Drug: Erlotinib Hydrochloride Sponsor: University of Texas Southwestern Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2019 Category: Research Source Type: clinical trials